Twitter Linkedin-in

Biomarkers Series UK

: Speakers

Speakers

18 - 20 February 2020 | Manchester, UK
Book Now

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for the 2020 Series.

Achim Kless

Achim Kless

Scientific Director, GI-PN-TSI and Principal Translational Scientist
Grunenthal
Ana Alfirevic

Ana Alfirevic

Professor, Molecular and Clinical Pharmacology
University of Liverpool
Andrew Pierce

Andrew Pierce

Associate Director - Translational Science Oncology
AstraZeneca
Anguraj Sadanandam

Anguraj Sadanandam

Team Leader, Systems and Precision Cancer Medicine
Institute of Cancer Research
Anka Ehrhardt

Anka Ehrhardt

Science Director
CHDI Foundation
Arun Satelli

Arun Satelli

Associate Director Target Biomarkers
Immatics
Philip Dunne

Axel Ducret

Project Leader
F. Hoffman-La Roche
Philip Dunne

Benoit Tyl

Director of Cardiovascular Translational Research
Servier
Birgitte Sogaard

Birgitte Sogaard

Senior Director Experimental Medicine
Lundbeck
Philip Dunne

Brad Evans

Associate Principal Scientist
MSD
Chanchal Kumar

Chanchal Kumar

Associate Director (Team Leader), CVMD Bioinformatics, Translational Sciences
AstraZeneca
Philip Dunne

Charles Cox

Head of Pharmacogenomics
GlaxoSmithKline
Christie Fanton

Christie Fanton

Director, Translational Research
Nektar Therapeutics
Cornelia Dorner-Ciossek

Cornelia Dorner-Ciossek

Director in Discovery Research, CNS
Boehringer Ingelheim
Deepti Aurora-Garg

Deepti Aurora-Garg

Director, Companion Diagnostics
MSD
Philip Dunne

Erik Vollebregt

Partner
Axon Lawyers
Philip Dunne

Georges Dagher

Research Director
INSERM
Gerard Sanderink

Gerard Sanderink

Global Head Biomarkers & Clinical Bioanalyses
Sanofi
Ginette Serrero

Ginette Serrero

Chief Executive Officer
A&G Pharmaceuticals
Philip Dunne

Graham Pockley

Director & Professor of Immunobiology
Nottingham Trent University
Holly Soares

Holly Soares

Head of Precision Medicine and Vice President
Pfizer
Igor Rudychev

Igor Rudychev

Head of US Digital, Data and Innovations
AstraZeneca
Jane Wilkinson

Jane Wilkinson

Senior Director, Broad Genomics Alliance & Project Management
Broad Institute
Philip Dunne

Jenny Zhang

Associate Director/Senior Manager, Clinical Biomarker Assay Specialist
Pfizer
Philip Dunne

Jim Turk

Pathology Director; Lead, Translational Cardiovascular Pathology and Biomarkers
Amgen
Philip Dunne

Jiri Aubrecht

Scientific Director, Translational Biomarker Research
Takeda
Philip Dunne

John-Michael Sauer

Program Officer, Biomarker Programs and Executive Director, Predictive Safety Testing Consortium
C-Path Institute
Katherine Call

Katherine Call

Senior Director and Head, Proteogenomics
Sanofi
Ken Chang

Ken Chang

Director, Clinical Biomarkers
Daiichi Sankyo
Philip Dunne

Liz Harrington

Executive Director, Head of Translational Science UK, Oncology IMED Business Unit
AstraZeneca
Philip Dunne

Maggie Cheang

Team Leader
Institute of Cancer Research
Philip Dunne

Marc Yeste-Velasco

Director, Translational Research
Ability Pharma
Marco Ranzani

Marco Ranzani

Senior Scientist
Artios Pharma
Marianne Scheel-Fjording

Marianne Scheel-Fjording

Senior Clinical Director
Novo Nordisk
Mario Richter

Mario Richter

Associate Director DMPK-BA, Operations Large Molecules and Biomarkers
AbbVie
Mark Fidock

Mark Fidock

Vice President & Head of Precision Medicine Diagnostic Development
AstraZeneca
Markus Zettl

Markus Zettl

Director, Immuno-Oncology
Pieris Pharmaceuticals
Philip Dunne

Michelle Morrow

Vice President, Preclinical Translational Pharmacology
F-Star Therapeutics
Miro Venturi

Miro Venturi

Senior Vice President, Biomarkers
Roche
Patrick Kleyn

Patrick Kleyn

Vice President, Translational R&D
Rhythm Pharmaceuticals
Philip Dunne

Philip Dunne

Lecturer, Centre for Cancer Research and Cell Biology
Queen's University Belfast
Philip Dunne

Philip Murphy

Head, Imaging
GlaxoSmithKline
Pia Davidsson

Pia Davidsson

Head of Biomarkers, Discovery and Development, Translational Science and Experimental Medicine
AstraZeneca
Rachel Salisbury

Rachel Salisbury

Regional Clinical Director, European Clinical Development
MSD
Philip Dunne

Richard Batrla-Utermann

Medical Director
Roche
Roy Baynes

Roy Baynes

Senior Vice President, Head of Global Clinical Development, Chief Medical Officer
MSD
Philip Dunne

Sudhir Srivastava

Chief, Cancer Biomarkers
NIH
Tarek Leil

Tarek Leil

Head - Quantitative Clinical Pharmacology
Bristol-Myers Squibb
Philip Dunne

Thomas Joos

Deputy Managing Director
NMI Natural and Medical Science Institute
Thomas Misko

Thomas Misko

Lead Scientist & Senior Scientific Director, Translational Neuroscience
AbbVie
Philip Dunne

Tim Erkens

Senior Scientist, Biomarkers & Clinical Pathology, Nonclinical Safety
Janssen
Yael Silberberg

Yael Silberberg

Director of Data Science
BiomX
Yong-Jie Lu

Yong-Jie Lu

Professor in Molecular Oncology
Queen Mary University of London
Ziad Taib

Ziad Taib

Statistics Science Director
AstraZeneca

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.